Trading News

Wells initiates Pfizer at overweight, says Covid treatments are here to stay


A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020.

Dado Ruvic | Reuters

Pfizer is poised to outperform as its Covid treatments stick around and generate major revenue for the company, according to Wells Fargo.

CVS says it expects sales to accelerate as it expands its range of health-care services

Previous article

Uber-owned Careem gets in on the surging rapid grocery delivery market with UAE launch

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Trading News